How effective is Sprycel for Leukaemia ?


Summary

4 Sprycel users have rated its effectiveness for Leukaemia.

Overall ratings: 4.8/5
Long term ratings: 5/5

This is a reivew of how effective Sprycel (dasatinib) is for Leukaemia and for what kind of people. The study is created by eHealthMe and is updated continuously.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Jul, 18, 2017

4 people are studied for taking Sprycel in Leukaemia


Overall effectiveness (number of people)

Does Sprycel work for your Leukaemia (overall)?

Long term effectiveness (number of people)

Does Sprycel work for your Leukaemia (long term)?

Sprycel effectiveness for Leukaemia (number of people)

Overall:
  • not at all: 0
  • somewhat: 0
  • moderate: 0
  • high: 1
  • very high: 3
Long Term:
  • not at all: 0
  • somewhat: 0
  • moderate: 0
  • high: 0
  • very high: 2

Gender of people who take Sprycel for Leukaemia *

  • female: 50 %
  • male: 50 %

Age of people who take Sprycel for Leukaemia *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 25 %
  • 50-59: 50 %
  • 60+: 25 %

Who finds Sprycel more effective for Leukaemia?


Gender of people who take Sprycel for Leukaemia *

  • female: 50 %
  • male: 50 %

Age of people who take Sprycel for Leukaemia *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 25 %
  • 50-59: 50 %
  • 60+: 25 %

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

Sprycel

Sprycel has active ingredients of dasatinib. It is often used in chronic myelogenous leukemia (cml). (latest outcomes from Sprycel 11,761 users)

Leukaemia

Leukaemia (blood or bone marrow cancer) has been reported by people with multiple sclerosis, myelodysplastic syndrome, rheumatoid arthritis, osteoporosis, primary myelofibrosis (latest reports from 6,366 Leukaemia patients).

Related studies: